PUBLISHER: Grand View Research | PRODUCT CODE: 2067609
PUBLISHER: Grand View Research | PRODUCT CODE: 2067609
The global ultrasound devices market size was estimated at USD 11.4 billion in 2025 and is projected to reach USD 16.4 billion by 2033, growing at a CAGR of 4.66% from 2026 to 2033. The market growth is anticipated to be driven by the rising use of ultrasound equipment for diagnostic imaging and treatment, as well as the rising prevalence of chronic and lifestyle-related diseases.
Other factors influencing the market growth include increased demand for minimally invasive surgeries and developments in ultrasound imaging technology. Ultrasound is considered one of the most valuable diagnostic tools in medical imaging, as it is both faster and less expensive than other imaging systems. In addition, as it does not use magnetic fields or ionizing radiation, it is safer than other imaging technologies.
Both diagnostic and therapeutic uses for the ultrasonic medical device are extensive. Specific therapeutic applications of ultrasound, from oncology to cardiology, have grown in popularity. The development of wireless transducers, app-based ultrasound technology, fusion with CT/MR, laparoscopic ultrasound, and the expansion of ultrasound device applications in 3D imaging and shear wave elastography are expected to support market growth. For instance, in March 2023, KronosMD, INC., a division of Kronos Advanced Technologies Inc., confirmed its acquisition of all current and future properties and patents related to its planned breakthrough 3D ultrasonic dentistry imaging and diagnostic equipment.
As the transaction approaches completion, it aims to boost the industrialization of the S-WAVETM system and S-WAVETM ultrasonic imaging equipment. Currently, manufacturers are focusing on expanding the applications of their products in radiology. Radiologists still utilize 2-D ultrasound imaging for examinations, even though 3-D/4-D volume imaging in obstetrics and gynecology, and 4DUS imaging are used to visualize heart wall movements. Manufacturers and scientists have driven interest in the global market due to improved imaging quality and workflow, and growing awareness about radiation dose issues with other imaging modalities. Real-time ultrasound imaging can be very important in the emerging field of fusion imaging.
The rising use of ultrasound equipment for diagnostic imaging & therapy and the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipated to drive market growth. Ultrasound technology is used in various application areas, such as cardiology, obstetrics/gynecology, vascular, orthopedic, & general imaging. The rising prevalence of cardiac disorders is expected to boost overall market growth. According to the WHO, Cardiovascular Diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives annually. In addition, as per the CDC, in the U.S., every year, about 805,000 people have a heart attack, and about one in 20 adults (about 5%) aged 20 years & older have coronary artery disease.
In addition, a new report published by the WHO suggests that nearly 17.5% of adult inhabitants, around one in six worldwide, have infertility, creating an urgent demand for affordable & high-quality fertility care. Moreover, according to the American Society of Clinical Oncology (ASCO), around 66,200 U.S. inhabitants are expected to be diagnosed with uterine or endometrial cancer in 2023. Every year, the number of people detected with uterine cancer in the U.S. is increasing by around 2% in women aged 49 years & below and by 1% in women older than that. Ultrasound devices are used to assess the pelvic anatomy of the uterus, including the uterine lining & bilateral ovaries. These factors drive the market growth.
Major players are working to improve their product offerings by upgrading their offerings, leveraging key partnerships, and exploring acquisitions and government clearances to expand their customer base and gain a larger market share. For instance, in March 2023, Siemens Healthineers announced the evolution of the Acuson Sequoia Flagship series of ultrasound devices at the 2023 European Congress of Radiology (ECR) in Vienna.
In addition, in February 2023, Boston Imaging launched the Hera W10 Elite, the exclusive model of the Hera platform for obstetrics and gynecology, providing clinicians with powerful AI tools and clinical applications to enhance the diagnostic experience. Boston Imaging is the U.S. headquarters for marketing, sales, and distribution of all Samsung digital radiography and ultrasound systems.
Global Ultrasound Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ultrasound devices market report based on the product, portability, application, end use, and region: